Exodus Point Capital Management, LP Astrazeneca PLC Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $6.46 Million - $7.36 Million	-105,826 Reduced 42.13%	145,355 $9.85 Million
Q3 2023 Nov 09, 2023	BUY	$64.85 - $71.7 $15 Million - $16.6 Million	231,042 Added 1147.24%	251,181 $17 Million
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $14.2 Million - $15.4 Million	-202,787 Reduced 90.97%	20,139 $1.44 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $14.1 Million - $16 Million	222,926 New	222,926 $15.5 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $3.07 Million - $7.86 Million	57,915 New	57,915 $3.18 Million
Q2 2022 Aug 19, 2022	SELL	$59.26 - $71.14 $363,026 - $435,803	-6,126 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $21,953 - $26,445	-394 Reduced 6.04%	6,126 $406,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $3.63 Million - $4.29 Million	-67,163 Reduced 91.15%	6,520 $380,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $560,655 - $613,431	10,091 Added 15.87%	73,683 $4.43 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $3.08 Million - $3.83 Million	63,592 New	63,592 $3.81 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $792,806 - $915,190	-16,811 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $205,094 - $245,250	-4,227 Reduced 20.09%	16,811 $840,000
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $796,103 - $916,561	15,001 Added 248.48%	21,038 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $260,194 - $333,906	6,037 New	6,037 $319,000
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $562,201 - $637,171	-14,013 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $108,820 - $121,663	2,919 Added 26.31%	14,013 $578,000
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $393,726 - $477,263	11,094 New	11,094 $449,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account